Drug:
Reaction: ASTHMA
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26545306 |
US |
||
Product dose omission issue, Asthma, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 102 | 26545333 |
44 | 2 | |
Hospitalisation, Chronic respiratory failure, Pulmonary embolism, Right ventricular failure, Asthma, Hypothyroidism, Dyspnoea, Influenza like illness, Cough, Pyrexia, Productive cough, Headache, Dyspnoea, Oxygen saturation decreased, |
||||
RIOCIGUAT, RIOCIGUAT, OXYGEN, 0XYGEN, |
||||
| 103 | 26545563 |
US |
2 | |
Asthma, Product dose omission issue, Device issue, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 104 | 26545576 |
EU |
31 | 2 |
Depression, Gait disturbance, Breast mass, Tension, Pain, Heart rate increased, Alopecia, Blood immunoglobulin G decreased, Gait disturbance, Fatigue, Stomatitis, Sleep disorder, Weight increased, Cough, Asthma, Oropharyngeal pain, Off label use, Fall, Bronchitis, Neuralgia, Agitation, Muscle spasticity, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, BACLOFEN, BACLOFEN, BACLOFEN, BACLOFEN, BACLOFEN, BACLOFEN, AMITRIPTYLINE HYDROCHLORIDE, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, HYDROCORTISONE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, AMANTADINE, CANDESARTAN, AMLODIPINE, |
||||
| 105 | 26545685 |
1 | ||
Asthma, Impaired quality of life, Intestinal obstruction, |
||||
OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CETIRIZINE HCL, CETIRIZINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), EPINEPHRINE, ADRENALINUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 106 | 26546021 |
US |
63 | 2 |
Dyspnoea, Influenza, Asthma, Emphysema, Condition aggravated, |
||||
DUPILUMAB, |
||||
| 107 | 26546023 |
US |
67 | 2 |
Fatigue, Asthma, Muscle spasms, |
||||
DUPILUMAB, |
||||
| 108 | 26546186 |
EU |
64 | 1 |
Poisoning deliberate, Asthma, Drug abuse, |
||||
BUPRENORPHINE, LORAZEPAM, |
||||
| 109 | 26546270 |
US |
1 | |
Asthma, Pneumonia, Nasopharyngitis, |
||||
OMALIZUMAB, NEMOLIZUMAB-ILTO, |
||||
| 110 | 26536207 |
JP |
36 | 1 |
Asthma, Erythema, |
||||
ROCURONIUM BROMIDE, REMIMAZOLAM BESYLATE, SEVOFLURANE, CEFAZOLIN SODIUM, CEFAZOLIN, |
||||
| 111 | 26536405 |
US |
61 | 2 |
Loss of personal independence in daily activities, Mobility decreased, Fall, Limb injury, Anaemia, Illness, Nervousness, Pain, Asthma, |
||||
ETANERCEPT, |
||||
| 112 | 26536502 |
CA |
78 | 2 |
Aspiration, Abdominal pain upper, Upper respiratory tract infection, Pneumonia, Pulmonary fibrosis, Lower respiratory tract infection, Hypoxia, Bronchiectasis, Anaemia, Asthma, Blood calcium increased, Blood test abnormal, Bronchopulmonary aspergillosis allergic, Gastrooesophageal reflux disease, Haemoptysis, Lung opacity, Musculoskeletal stiffness, Obstructive airways disorder, Pleural effusion, Rales, Sputum discoloured, Total lung capacity decreased, Wheezing, Pain, General physical health deterioration, Pulmonary mass, Dyspnoea, Oedema peripheral, Pyrexia, Constipation, Asthenia, Fatigue, Tremor, Headache, Blood creatinine increased, Transaminases increased, Liver function test increased, Drug hypersensitivity, Cough, Product dose omission issue, Drug ineffective, Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, ROSUVASTATIN CALCIUM, CANDESARTAN CILEXETIL, DEXLANSOPRAZOLE, LANSOPRAZOLE, MORPHINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, EFINACONAZOLE, NITROGLYCERIN, BUDESONIDE, |
||||
| 113 | 26537125 |
US |
58 | 2 |
Pneumonia, Asthma, |
||||
DUPILUMAB, MOMETASONE FUROATE, IPRATROPIUM BROMIDE, BENZONATATE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, CROMOLYN SODIUM, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, GABAPENTIN, LEVALBUTEROL HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PROGESTERONE, PANTOPRAZOLE SODIUM, PYRIDOSTIGMINE BROMIDE, IVERMECTIN, UREA, URSODIOL, URSOSIOL, CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 114 | 26537299 |
US |
63 | 2 |
Intercepted product storage error, Product use issue, Asthma, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 115 | 26537828 |
US |
33 | 2 |
Anxiety, Cardiac flutter, Pericardial effusion, Palpitations, Muscle oedema, Pleural effusion, Dyspnoea, Panic attack, Heart rate irregular, Dyspnoea, Asthma, Upper respiratory tract infection, Cough, Nasal congestion, |
||||
ASCIMINIB, |
||||
| 116 | 26537881 |
CA |
2 | |
COVID-19, Arthralgia, Asthma, Respiratory syncytial virus infection, Foot fracture, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, IPRATROPIUM BROMIDE AND ALBUTEROL, IPRATROPIUM BROMIDE AND ALBUTEROL, UMECLIDINIUM, UMECLIDINIUM, |
||||
| 117 | 26537900 |
US |
73 | 2 |
Somnolence, Pain, Pyrexia, Influenza like illness, Injection site erythema, Asthma, |
||||
DUPILUMAB, EMPAGLIFLOZIN, MONTELUKAST SODIUM, MONTELUKAST, MIRABEGRON, SERTRALINE HYDROCHLORIDE, SPIRONOLACTONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CARVEDILOL, CLONIDINE HYDROCHLORIDE, VALSARTAN, VALSARTAN ORAL, AMITRIPTYLINE HYDROCHLORIDE, AMLODIPINE BESYLATE, FUROSEMIDE, TIRZEPATIDE, INSULIN GLARGINE, CETIRIZINE HYDROCHLORIDE, MELATONIN, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, TIRZEPATIDE, VALSARTAN, VALSARTAN ORAL, AMLODIPINE BESYLATE, SERTRALINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE, |
||||
| 118 | 26537932 |
US |
59 | 1 |
Asthma, |
||||
DUPILUMAB, DEXAMETHASONE SODIUM PHOSPHATE, |
||||
| 119 | 26537935 |
US |
69 | 2 |
Asthma, |
||||
DUPILUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, LEVALBUTEROL TARTRATE, MONTELUKAST SODIUM, MONTELUKAST, CROMOLYN SODIUM, |
||||
| 120 | 26537948 |
US |
43 | 2 |
Dermatitis atopic, Rash, Discomfort, Sleep disorder due to a general medical condition, Asthma, Cough, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 121 | 26538097 |
US |
2 | |
Rash, Asthma, |
||||
DUPILUMAB, |
||||
| 122 | 26538100 |
US |
16 | 1 |
Palpitations, Asthma, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE, |
||||
| 123 | 26538575 |
AR |
15 | 2 |
Bronchospasm, Prescribed underdose, Off label use, Asthma, |
||||
NATALIZUMAB, NATALIZUMAB, LACOSAMIDE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 124 | 26538751 |
CA |
2 | |
Intestinal obstruction, Asthma, |
||||
ADALIMUMAB-BWWD, |
||||
| 125 | 26538784 |
US |
43 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 126 | 26538787 |
US |
80 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 127 | 26539344 |
EU |
56 | 2 |
Asthma, |
||||
POLIDOCANOL, |
||||
| 128 | 26539793 |
US |
73 | 2 |
Diabetes mellitus, Sinusitis, Hypoaesthesia, Back pain, Pain in extremity, Asthma, Wrong technique in device usage process, Drug ineffective, Product complaint, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROSUVASTATIN, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, CETIRIZINE HYDROCHLORIDE, |
||||
| 129 | 26540177 |
CA |
48 | 2 |
Asthma, Diabetes mellitus, Hypertension, Hypothyroidism, |
||||
PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE, AMLODIPINE BESYLATE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, LEVOTHYROXINE SODIUM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ARIPIPRAZOLE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, BUPROPION, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, |
||||
| 130 | 26540220 |
GB |
53 | 2 |
Asthma, Concomitant disease aggravated, Nephrolithiasis, |
||||
SECUKINUMAB, SECUKINUMAB, BECLOMETHASONE DIPROPIONATE, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, |
||||
| 131 | 26541006 |
US |
60 | 1 |
Dyspnoea, Asthma, |
||||
DUPILUMAB, |
||||
| 132 | 26541208 |
EU |
64 | 1 |
Drug abuse, Poisoning deliberate, Asthma, |
||||
BUPRENORPHINE, LORAZEPAM, LORAZEPAM, |
||||
| 133 | 26541532 |
CA |
75 | 1 |
Asthma, Cardiac failure congestive, Chronic obstructive pulmonary disease, Dyspnoea, Full blood count abnormal, Lung disorder, Muscle spasms, Neuropathy peripheral, Paraesthesia, Pneumonia, Sensory disturbance, Sleep disorder due to a general medical condition, Sputum discoloured, Tachycardia, Therapeutic product effect incomplete, Therapeutic response shortened, Wheezing, Chest discomfort, Dyspnoea exertional, Reversible airways obstruction, Weight increased, Cough, |
||||
DEXLANSOPRAZOLE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, BUDESONIDE, ROFLUMILAST, METRONIDAZOLE, METRONIDAZOLE TOPICAL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, ALBUTEROL SULFATE, BENRALIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, BUPRENORPHINE, GABAPENTIN ENACARBIL, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MOMETASONE FUROATE, MOMETASONE, MONTELUKAST, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MEPOLIZUMAB, MEPOLIZUMAB, OMALIZUMAB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, PREGABALIN, TIOTROPIUM BROMIDE, GLYCOPYRROLATE, MONTELUKAST SODIUM, DUPILUMAB, CEPHALEXIN, CALCIUM CARBONATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
| 134 | 26544870 |
1 | ||
Asthma, |
||||
RISANKIZUMAB-RZAA, ABALOPARATIDE, |
||||
| 135 | 26544938 |
1 | ||
Asthma, |
||||
TEZEPELUMAB-EKKO, RISANKIZUMAB-RZAA, |
||||
| 136 | 26532292 |
US |
||
Asthma, |
||||
DAPAGLIFLOZIN, |
||||
| 137 | 26532365 |
18 | ||
Vomiting, Tachycardia, Asthma, Seizure, Mood altered, Anger, Drug ineffective, |
||||
LEVETIRACETAM, LEVETIRACETAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 138 | 26532411 |
US |
||
Asthma, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 139 | 26532424 |
US |
||
Asthma, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 140 | 26532526 |
US |
2 | |
Asthma, |
||||
TILDRAKIZUMAB-ASMN, |
||||
| 141 | 26532639 |
US |
65 | 2 |
Necrotising fasciitis, Breast cancer, Chronic kidney disease, COVID-19, Asthma, Osteoarthritis, Feeling abnormal, Weight decreased, Urinary tract infection, |
||||
VORTIOXETINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CARVEDILOL, LORAZEPAM, ALBUTEROL SULFATE, ALBUTEROL, MINOXIDIL, LETROZOLE, AMLODIPINE, ALLOPURINOL, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, METHOCARBAMOL, ERGOCALCIFEROL, VITAMIN C, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 142 | 26532749 |
US |
||
Asthma, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 143 | 26533110 |
US |
||
Asthma, |
||||
| 144 | 26533208 |
US |
37 | 2 |
Asthma, Nasal polyps, Condition aggravated, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 145 | 26533233 |
CA |
43 | 2 |
Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Adverse drug reaction, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Depression, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Fatigue, Ear pain, Epilepsy, Exostosis, Facet joint syndrome, Feeling hot, Folliculitis, Fibromyalgia, Frequent bowel movements, Gait disturbance, Gait inability, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Infusion site reaction, Injection site reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Laboratory test abnormal, Laryngitis, Lip dry, Liver function test increased, Live birth, Liver disorder, Normal newborn, Maternal exposure during pregnancy, Incorrect route of product administration, Drug ineffective, Intentional product use issue, Intentional product misuse, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, APREMILAST, APREMILAST, APREMILAST, ATOMOXETINE, AZATHIOPRINE, CELECOXIB, CELECOXIB, CELECOXIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, BOTULINUM TOXIN TYPE A, MEPOLIZUMAB, BUPRENORPHINE, BUPRENORPHINE, ACETAMINOPHEN AND CODEINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LANSOPRAZOLE, LISINOPRIL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL, |
||||
| 146 | 26533283 |
US |
59 | 2 |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 147 | 26533493 |
US |
72 | 1 |
Asthma, Cough, |
||||
DUPILUMAB, |
||||
| 148 | 26534206 |
US |
2 | |
Fatigue, Asthma, Urticaria, |
||||
OMALIZUMAB, DUPILUMAB, |
||||
| 149 | 26534230 |
US |
44 | 2 |
Retinal detachment, Dyspnoea, Asthma, White blood cell count decreased, Immunodeficiency, Respiratory tract congestion, Lower respiratory tract infection, Rash, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 150 | 26534253 |
US |
66 | 2 |
Asthma, Muscle twitching, Nausea, Insomnia, Dyskinesia, Tic, Fatigue, Drug ineffective, |
||||
DEUTETRABENAZINE, |
||||
| 151 | 26534299 |
US |
63 | 2 |
Haemorrhage, Asthma, |
||||
DUPILUMAB, ZOLPIDEM TARTRATE, AMLODIPINE, LOSARTAN POTASSIUM, LOSARTAN, LEVOTHYROXINE SODIUM, |
||||
| 152 | 26534471 |
US |
50 | 2 |
Asthma, Drug ineffective, |
||||
DUPILUMAB, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PROGESTERONE, ROSUVASTATIN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, VITAMIN C, |
||||
| 153 | 26534552 |
2 | ||
Sarcoidosis, Condition aggravated, Asthma, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 154 | 26534571 |
EU |
67 | 1 |
Condition aggravated, Asthma, Product substitution issue, |
||||
OMALIZUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 155 | 26534652 |
US |
2 | |
Asthma, Pneumonia streptococcal, Nasopharyngitis, |
||||
OMALIZUMAB, |
||||
| 156 | 26535037 |
US |
||
Atrial fibrillation, Asthma, Therapy change, Off label use, Distractibility, Extra dose administered, Panic reaction, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 157 | 26535138 |
US |
50 | 2 |
Asthma, Quality of life decreased, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, EPINEPHRINE, ADRENALINUM, BENRALIZUMAB, PHENTERMINE HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 158 | 26526876 |
US |
2 | |
Cardiac operation, Cardiac pacemaker insertion, Sinus pain, Asthma, Dysphonia, Nasopharyngitis, Multiple allergies, |
||||
MEPOLIZUMAB, |
||||
| 159 | 26527181 |
CA |
44 | 2 |
Bursitis, Dizziness, Asthenia, C-reactive protein abnormal, Alopecia, Adverse event, Asthma, Abdominal pain upper, Adverse drug reaction, Blister, Blood cholesterol increased, Diarrhoea, Discomfort, Abdominal discomfort, Arthropathy, Confusional state, Condition aggravated, Abdominal pain, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREGABALIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 160 | 26527265 |
57 | ||
Lower respiratory tract infection, Asthma, Sinusitis, Malaise, Therapeutic product effect incomplete, |
||||
BIMEKIZUMAB, |
||||
| 161 | 26527326 |
US |
2 | |
Asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 162 | 26527475 |
EU |
1 | |
Allergic bronchitis, Asthma, |
||||
LENALIDOMIDE, |
||||
| 163 | 26527810 |
44 | 2 | |
Asthma, |
||||
LEVONORGESTREL, DUPILUMAB, |
||||
| 164 | 26528075 |
US |
2 | |
Glaucoma, Blood pressure abnormal, Rash macular, Alopecia, Vision blurred, Eye pruritus, Asthma, |
||||
DUPILUMAB, MINOXIDIL, ALBUTEROL SULFATE, ALBUTEROL, VALSARTAN, DORZOLAMIDE, LATANOPROST, LEFLUNOMIDE, PREDNISONE, PANTOPRAZOLE SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ERGOCALCIFEROL, |
||||
| 165 | 26528428 |
CN |
72 | 2 |
Dyspnoea, Asthma, Wrong technique in product usage process, Product dose omission issue, Oxygen saturation decreased, Device delivery system issue, Taste disorder, |
||||
| 166 | 26528538 |
US |
2 | |
Asthma, Illness, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 167 | 26528706 |
US |
2 | |
Skin ulcer, Asthma, Fatigue, Hypersomnia, Illness, Pain, Mastocytosis, Bipolar disorder, Pruritus, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, FAMOTIDINE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, LAMOTRIGINE, CARIPRAZINE, GABAPENTIN, EPINEPHRINE, |
||||
| 168 | 26528895 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Malaise, Pain, Oedema, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
RITUXIMAB, OMALIZUMAB, |
||||
| 169 | 26529184 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Malaise, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, AMLODIPINE BESYLATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, RISEDRONATE SODIUM, RITUXIMAB, CALCIUM CARBONATE, ANTACID, BECLOMETHASONE DIPROPIONATE, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CLONAZEPAM, ROSUVASTATIN, ERGOCALCIFEROL, PREDNISONE, TRAMADOL HYDROCHLORIDE, |
||||
| 170 | 26529399 |
1 | ||
Asthma, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 171 | 26530907 |
US |
2 | |
Asthma, Product dose omission issue, Product packaging issue, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 172 | 26530940 |
EU |
2 | |
Asthma, COVID-19, Product dose omission issue, |
||||
| 173 | 26530993 |
CA |
32 | |
Abdominal pain, Anxiety, Asthma, Blood pressure increased, Eczema, Emphysema, Forced expiratory volume decreased, Heart rate increased, Middle insomnia, Migraine, Nasal congestion, Obstructive airways disorder, Oropharyngeal pain, Productive cough, Psoriasis, Restrictive pulmonary disease, Rhinitis, Sleep disorder, Stress, Tachycardia, Terminal insomnia, Upper-airway cough syndrome, Vomiting, Tooth abscess, Wheezing, Dyspnoea, Ear infection, Nasopharyngitis, Sinusitis, Diarrhoea, Cough, Urticaria, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, QUETIAPINE FUMARATE, QUETIAPINE, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TERBUTALINE SULFATE, IPRATROPIUM BROMIDE, AMLODIPINE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EPINEPHRINE, CICLESONIDE, SEMAGLUTIDE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 174 | 26531007 |
BR |
51 | 2 |
Asphyxia, Fatigue, Asthma, Off label use, Device use issue, Device malfunction, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 175 | 26522892 |
CA |
32 | |
Abdominal pain, Anxiety, Asthma, Bacterial infection, Blood pressure increased, Decreased activity, Dyspnoea, Dyspnoea exertional, Ear infection, Eczema, Emphysema, Eosinophil count abnormal, Feeding disorder, Forced expiratory volume decreased, Full blood count abnormal, Fungal infection, Heart rate increased, Infection, Influenza, Malaise, Middle insomnia, Migraine, Musculoskeletal chest pain, Nasal congestion, Nasal discharge discolouration, Nasopharyngitis, Obstructive airways disorder, Oropharyngeal pain, Pain, Pneumonia, Productive cough, Psoriasis, Rales, Restrictive pulmonary disease, Rhinitis, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Stress, Tachycardia, Terminal insomnia, Tooth abscess, Upper-airway cough syndrome, Urinary tract infection, Vertigo, Vomiting, Wheezing, Cough, Dizziness, Diarrhoea, Urticaria, Drug ineffective, Product administration error, Therapeutic response decreased, Therapeutic product effect decreased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, MONTELUKAST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TERBUTALINE SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EPINEPHRINE, EPINEPHRINE, CICLESONIDE, QUETIAPINE FUMARATE, QUETIAPINE, SEMAGLUTIDE, SEMAGLUTIDE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 176 | 26523063 |
US |
||
Near death experience, Asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 177 | 26523550 |
38 | ||
Breast abscess, Candida infection, Asthma, Intertrigo, Psoriasis, |
||||
BIMEKIZUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, MIRTAZAPINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, |
||||
| 178 | 26523666 |
US |
11 | 2 |
Asthma, Dyspnoea, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 179 | 26524001 |
CO |
26 | 1 |
Asthma, Insomnia, Chest discomfort, Skin lesion, Pruritus, |
||||
UPADACITINIB, DUPILUMAB, |
||||
| 180 | 26524268 |
GB |
58 | 1 |
Wheezing, Asthma, |
||||
NAPROXEN, NAPROXEN SODIUM, LANSOPRAZOLE, |
||||
| 181 | 26524272 |
CA |
51 | 1 |
Chronic obstructive pulmonary disease, Thoracic cavity drainage, Asthma, Productive cough, Malaise, Headache, Chest pain, Tachycardia, Hyperhidrosis, Feeling abnormal, Abdominal pain upper, Back pain, Contusion, Fall, Neck pain, Arthralgia, Hypoaesthesia, Intervertebral disc protrusion, Inappropriate schedule of product administration, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, PREDNISONE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 182 | 26524497 |
US |
36 | 2 |
Asthma, Extra dose administered, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, MONTELUKAST, AMLODIPINE BESYLATE, |
||||
| 183 | 26524619 |
US |
45 | 2 |
Asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 184 | 26525069 |
US |
2 | |
Off label use, Blood magnesium decreased, Asthma, Influenza like illness, Confusional state, Urinary tract infection, Blood potassium decreased, Decreased appetite, Diarrhoea, Vomiting, Asthenia, Vaginal haemorrhage, Sinusitis, Influenza, Anxiety, Headache, Abdominal pain upper, Fatigue, |
||||
OSILODROSTAT, OSILODROSTAT, OSILODROSTAT, MIFEPRISTONE, |
||||
| 185 | 26525073 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
OMALIZUMAB, RITUXIMAB, CLONAZEPAM, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 186 | 26525718 |
EU |
||
Poisoning deliberate, Asthma, Drug abuse, |
||||
BUPRENORPHINE, LORAZEPAM, |
||||
| 187 | 26526014 |
CA |
63 | 2 |
Death, Chronic obstructive pulmonary disease, Asthma, Dyspnoea, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
| 188 | 26526508 |
GB |
2 | |
Kidney infection, Asthma, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 189 | 26526678 |
US |
2 | |
Asthma, Hypersensitivity, Blood test abnormal, Nervousness, Respiratory tract infection viral, |
||||
ECULIZUMAB, |
||||
| 190 | 26522122 |
US |
2 | |
Injection site pain, Asthma, Activities of daily living decreased, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, MONTELUKAST SODIUM, MONTELUKAST, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 191 | 26522269 |
US |
56 | 2 |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, CETIRIZINE HYDROCHLORIDE, |
||||
| 192 | 26522308 |
US |
66 | 2 |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 193 | 26522316 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
FLUTICASONE FUROATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, AMINOPHYLLINE, AMLODIPINE, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, HYDROMORPHONE HYDROCHLORIDE, OMALIZUMAB, PREDNISOLONE SODIUM PHOSPHATE, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, TRAMADOL HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 194 | 26522340 |
US |
66 | 2 |
Asthma, Wrong technique in device usage process, Drug ineffective, |
||||
FLUTICASONE FUROATE, |
||||
| 195 | 26522465 |
US |
||
Asthma, Urinary tract infection, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 196 | 26522476 |
US |
63 | 2 |
Asthma, Device malfunction, Device delivery system issue, Incorrect dose administered, |
||||
BECLOMETHASONE DIPROPIONATE, |
||||
| 197 | 26521373 |
US |
6 | 1 |
Illness, Cough, Vomiting, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 198 | 26521464 |
US |
54 | 2 |
Asthma, Sinusitis, |
||||
DUPILUMAB, BENRALIZUMAB, |
||||
| 199 | 26521599 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE, SERTRALINE HYDROCHLORIDE, |
||||
| 200 | 26521947 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, MONTELUKAST SODIUM, MONTELUKAST, PANTOPRAZOLE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28
